Figure 2.
Kaplan-Meier survival analysis of UBR5 expression in patients with gastric cancer. High UBR5 expression (≥0.9945 fold mRNA level) was associated with shorter survival time, whereas low UBR5 expression (<0.9945 fold mRNA level) was associated with longer survival time. UBR5, ubiquitin protein ligase E3 component N-recognin 5.